Clinical Trial Update: Study to Evaluate Immunogenicity, Reactogenicity and Safety of Rotarix™ Vaccine in Korean Infants [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating immunogenicity, reactogenicity and safety of Rotarix vaccine in Korean infants has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rotavirus Infectious Disease

Drugs mentioned

• Rotarix (Rotavirus vaccine (live attenuated))

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infections, Rotavirus, Rotavirus Vaccines | Phase 4 | Status: COMPLETED | Results posted: 2011-11-28